Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ

International Journal of Cancer

Volumn 129, Issue 10, 2011, Pages 2522-2526

  Sänger, Nicole ^a   Effenberger, Katharina E ^b   Riethdorf, Sabine ^b   Van Haasteren, Viviane ^c   Gauwerky, Johannes ^c   Wiegratz, Inka ^a   Strebhardt, Klaus ^a   Kaufmann, Manfred ^a   Pantel, Klaus ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Diakonie Medical Center   (Germany)

Author keywords

bone marrow; breast cancer; DCIs; disseminated tumor cells; micrometastasis; predictive factor; prognosis

Indexed keywords

CYTOKERATIN ANTIBODY; GONADORELIN; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BREAST BIOPSY; CANCER RELAPSE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED TUMOR CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INTRADUCTAL CARCINOMA; MASTECTOMY; MICROMETASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STEREOTACTIC BIOPSY; TUMOR CELL; VALIDATION STUDY;

ADULT; AGED; BONE MARROW; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 80052970594     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25895     Document Type: Article

References (25)

1. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005; 353: 793-802. (Pubitemid 41215488)
2. Pierga JY, Bidard FC, Mathiot C, Brain E, Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A, Marty M,. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 2008; 14: 7004-10.
3. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massague J,. Tumor self-seeding by circulating cancer cells. Cell 2009; 139: 1315-26.
4. Pantel K, Alix-Panabieres C, Riethdorf S,. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6: 339-51.
5. Pantel K, Brakenhoff RH, Brandt B,. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008; 8: 329-40. (Pubitemid 351596394)
6. Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Auvray H, Penault-Llorca F, Charpentier JC,. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer 2001; 37: 2365-72. (Pubitemid 33097472)
7. Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH, Waldman F,. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 2003; 95: 1692-702. (Pubitemid 37509078)
8. Sanders ME, Schuyler PA, Dupont WD, Page DL,. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005; 103: 2481-4. (Pubitemid 40800525)
9. Leonard GD, Swain SM,. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004; 96: 906-20. (Pubitemid 38868137)
10. Mokbel K, Cutuli B,. Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol 2006; 7: 756-65. (Pubitemid 44283669)
11. Silverstein MJ, Lagios M., Margin width as the sole predictor of local recurrence in patients with ductal carcinoma in situ of the breast. In:, Silverstain MJ, ed. Ductal carcinoma in situ of the breast, 2nd edn. Philadelphia: Lippincott, 2002. 482-93.
12. Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N,. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999; 86: 429-38. (Pubitemid 29347405)
13. Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, Rabban J, Chen YY, Kerlikowske K, Tlsty TD,. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 2007; 12: 479-91. (Pubitemid 350046408)
14. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G, Schlimok G,. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000; 342: 525-33. (Pubitemid 30117892)
15. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B,. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Breast Cancer Res Treat 2011; 125: 729-38.
16. Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E,. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 2006; 107: 885-92. (Pubitemid 44291136)
17. Borgen E, Pantel K, Schlimok G, Muller P, Otte M, Renolen A, Ehnle S, Coith C, Nesland JM, Naume B,. A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Cytometry B Clin Cytom 2006; 70: 400-9. (Pubitemid 44652076)
18. Naume B, Borgen E, Kvalheim G, Karesen R, Qvist H, Sauer T, Kumar T, Nesland JM,. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res 2001; 7: 4122-9. (Pubitemid 34048337)
19. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, Passlick B, Izbicki JR, Riethmuller G,. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994; 3: 165-73.
20. Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA,. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13: 58-68. (Pubitemid 350309740)
21. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K,. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005; 11: 8006-14. (Pubitemid 41698741)
22. Castro NP, Osorio CA, Torres C, Bastos EP, Mourao-Neto M, Soares FA, Brentani HP, Carraro DM,. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 2008; 10: R87.
23. Hilson JB, Schnitt SJ, Collins LC,. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol 2009; 33: 227-32.
24. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008; 13: 394-406. (Pubitemid 351609443)
25. Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, Bratthauer GL, Wheeler DT, Liang CY, Vinh TN, Strauss BL,. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res 2003; 5: R231-R241.